SCHEMBL19081724

SCHEMBL19081724

c1ccc2c(c1)ccc1c2oc2c(-c3c4ccccc4c(-c4ccc5c(c4)sc4ccccc45)c4ccccc34)cc3oc4ccccc4c3c21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 10/20 0.34
CYP1B1 Q16678 10/20 0.34
CYP1A2 P05177 9/20 0.34
ABCC1 P33527 4/20 0.34
ABCG2 Q9UNQ0 4/20 0.34
ABCB1 P08183 3/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
KDM4E B2RXH2 2/20 0.34
PRKDC P78527 2/20 0.34
HSD17B10 Q99714 2/20 0.34
MAPT P10636 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PDE5A O76074 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP19A1 P11511 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17944916 0.90 MAPT (0.36) ALDH1A1HPGDTDP1KDM4EPRKDC
SCHEMBL19081469 0.87 CYP1A1 (0.44) CYP1A1CYP1B1CYP1A2ABCC1ABCG2
SCHEMBL19081717 0.86 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2ABCC1ABCG2
SCHEMBL19081487 0.85 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2ABCC1ABCG2
SCHEMBL19081726 0.84 TDP1 (0.33) CYP1A1CYP1B1CYP1A2ABCC1ABCG2
SCHEMBL17944573 0.82 ALDH1A1 (0.39) ALDH1A1HPGDTDP1KDM4EPRKDC
SCHEMBL19081815 0.82 CYP1A1 (0.42) CYP1A1CYP1B1CYP1A2ABCC1ABCG2
SCHEMBL19081714 0.81 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2ABCC1ABCG2
SCHEMBL19081635 0.81 CYP1A1 (0.41) CYP1A1CYP1B1CYP1A2ABCC1ABCG2
SCHEMBL24519051 0.81 ALOX5 (0.39) ALDH1A1HPGDPRKDCMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.